Partner Headlines - ESRX

  1. Benzinga's Top Downgrades

    Benzinga
  2. Steven Romick Sells Microsoft, Walgreens, CVS

    GuruFocus
  3. Mike Khouw Sees Unusual Options Activity In Express Scripts

    Benzinga
  4. Anthem Looms Over Express

    IBD
  5. Express Scripts Gets Mixed Reviews After '16 Guidance

    IBD
  6. Stock Futures Trim Early Gains; Express Scripts, Spirit Air Climb

    IBD
  7. Benzinga's Top #PreMarket Gainers

    Benzinga
  8. First Pacific Advisors Slashes Stake in CVS Health

    GuruFocus
  9. Valeant To Cut Drug Prices In Team-Up With Walgreens

    IBD
  10. Health Care Stocks Play Prominent Roles in Steven Romick's Transactions

    GuruFocus
  11. Glenn Greenberg Sells Stake in Express Scripts Holding

    GuruFocus
  12. Motif Alert: Buybacks Have Bounced All The Way Back

    Benzinga
  13. Early Global News: Morgan Stanley To Cut Bond And Currency Trading ...

    Benzinga
  14. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  15. Express Scripts to Partner With Imprimis Pharmaceuticals to Offer ...

    Benzinga
  16. Premera Blue Cross and Express Scripts Agree to Contract Extension

    Benzinga
  17. Are Buybacks At Apple, Nike, Other Firms Good Or Bad?

    IBD
  18. CVS' Amgen Pick 'Raises The Bar' For Regeneron, Sanofi

    IBD
  19. Horizon Pharma Stock Rises After Depomed Chase Ends

    IBD
  20. Dodge & Cox Comments on Express Scripts

    GuruFocus
  21. Jeremy Grantham Adds to Stakes in Pharmaceutical Stocks

    GuruFocus
  22. Gilead, Regeneron Stocks Weather Drug Pricing Furor

    IBD
  23. Express Sues Horizon Pharma

    IBD
  24. Stocks End Modestly Lower; Popeyes Cooking After Hours

    IBD
  25. Horizon Slams Express Scripts Amid Pharmacy Dispute

    IBD
  26. Stock Futures Climb Toward Open; Facebook, LinkedIn, Alphabet ...

    IBD
  27. Horizon Pharma Soars On Big Q3 Beat, Guidance Raise

    IBD
  28. Valeant Dumps Philidor, Falls

    IBD
  29. Valeant Dumps Philidor As Stock Keeps Hemorrhaging

    IBD
  30. How Rite Aid Deal Will Change Walgreens

    GuruFocus
  31. Valeant Dumps Philidor As Stock Keeps Hemorrhaging

    IBD
  32. Herbalife Jabs Bill Ackman Over Troubled Valeant

    FoxBusiness
  33. Valeant Falls On CVS, Express

    IBD
  34. Valeant Hit As CVS, Express Scripts Dump Philidor

    IBD
  35. EXPRESS SCRIPTS

    IBD
  36. Walgreens Will Buy Rival Rite Aid In $17.2 Bil Deal

    IBD
  37. Steven Romick Sells CVS, Buys United Technologies

    GuruFocus
  38. Tuesday's After-Hours Movers: Apple And Twitter Lead The Way

    Benzinga
  39. Rite Aid Spikes 39% On Reported Walgreens Buy Talks

    IBD
  40. Horizon Pharma Counters Depomed Hit On Drug Pricing

    IBD
  41. FDA Ruling Shakes Up Biotech: Gilead, AbbVie And More

    Benzinga
  42. Stocks Near Flatline; Bad News for Lilly Is Good News For Regeneron

    IBD
  43. Stocks Fade After Solid Start; Tesla, Adobe Weigh On Nasdaq

    IBD
  44. Regeneron, Amgen Up As PCSK9s Gain Key Coverage

    IBD
  45. Stocks Surge In Mixed Volume; Amgen, Global Payments Rocket

    IBD
  46. EXPRESS SCRIPTS

    IBD
  47. Apple, Microsoft Lead '15 Payout Hikes But Pace Slows

    IBD
  48. Companies Returning Money to Shareholders at Record Rate

    GuruFocus
  49. Slowing Buybacks Drag On Buyback ETFs

    Benzinga
  50. Glenn Greenberg Acquires Two New Stakes

    GuruFocus
  51. Jeremy Grantham Reduces More Than 250 Stakes in Second Quarter

    GuruFocus
  52. Vanguard Health Care Fund Buys Two New Stakes in Second Quarter

    GuruFocus
  53. EXPRESS SCRIPTS

    IBD
  54. UnitedHealth Beats Views, Sits Pretty As Rivals Merge

    IBD
  55. UnitedHealth Set For Q2 Earnings Amid Deal Chatter

    IBD
  56. Will Bill Ackman Go After Express Scripts Next?

    GuruFocus
  57. Acquisitions May Fuel Gilead Sciences' Winning Ways

    IBD
  58. Horizon Pharma Seen In Deal-Making Mode

    IBD
  59. McKesson Sees Healthy Growth In Prescription Drugs

    IBD
  60. David Rolfe Adds to Most Valuable Stakes in His Portfolio

    GuruFocus
  61. Regeneron/Sanofi Cholesterol Drug Wins FDA Panel Vote

    IBD
  62. Gilead Nears Buy Zone On Healthy Drug Trial Results

    IBD
  63. Why Diplomat Pharmacy Gains Since IPO Look So Healthy

    IBD
  64. Horizon Pharma Survives Through Transformation

    IBD
  65. Morning Market Losers

    Benzinga
  66. Benzinga's Top Downgrades

    Benzinga
  67. Raymond James Downgrades Express Scripts Holding To Market Perform

    Benzinga
  68. Dodge & Cox Keeps Buying Express Scripts

    GuruFocus
  69. Pay-For-Performance Medicine

    Benzinga
  70. Making Money With Charles Payne: 05/26/15

    FoxBusiness
  71. Horizon Pharma Up On Bullish Leerink Initiation

    IBD
  72. CVS Health Buys Omnicare, Citing 'Long-Term' Benefits

    IBD
  73. Drug 'super spending' soars

    IBD
  74. 20 Questions With David Rolfe Part I

    GuruFocus
  75. Addiction Care Provider AAC Eyes National Brand

    IBD
  76. Medivation, Jazz Q1 Reports Miss; Regeneron Beats

    IBD
  77. Regeneron Q1 Earnings Beat As Eylea Research Pays Off

    IBD
  78. GoPro, Other Earnings Trigger Wild Price Swings

    IBD
  79. EXPRESS SCRIPTS

    IBD
  80. Express Scripts Posts In-Line Q1 Earnings, Issues Strong Forecast

    Benzinga
  81. Stocks Stumble To Early Losses; IPG Photonics Jumps

    IBD
  82. Why CVS Health And McKesson May Be Good Stock Picks

    IBD
  83. UnitedHealth Profit Soars On ObamaCare, Optum

    IBD
  84. UnitedHealth Up After Topping Views, Raising Outlook

    IBD
  85. UnitedHealth Eyes Biggest Earnings Gain In Years

    IBD
  86. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD
  87. Horizon Pharma Soars On Q4 Beat, Guidance Raise

    IBD
  88. Catamaran EPS Tops, But Stock Falls On Weak Guidance

    IBD
  89. 10 Stocks You Should Be Watching Today

    Benzinga
  90. EXPRESS SCRIPTS

    IBD
  91. UPDATE: Express Scripts Tops Q4 Expectations, Shares Rise After ...

    Benzinga
  92. Nasdaq Stretches Win Streak To 9 Days

    IBD
  93. Earnings Scheduled For February 23, 2015

    Benzinga
  94. Must Watch Stocks for Today

    Benzinga
  95. Stocks Cap Short Week With Gains; Salix Up On Buyout Hopes

    IBD
  96. Rolfe Adds One Company to Portfolio in Fourth Quarter

    GuruFocus
  97. Analyzing Needham Growth Fund's Pick: Express Scripts (ESRX)

    GuruFocus
  98. Analyzing Needham Growth Fund's Pick: CarMax (KMX)

    GuruFocus
  99. Rite Aid Stock Soars, Steps Up Competition With CVS

    IBD
  100. Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's ...

    GuruFocus
Trading Center